Christina Lee Chung

Christina Lee Chung, MD, FAAD, currently serves as the Lead Founder and Inventor at Hayflick Partners, focused on developing FDA-approved topical therapeutics for aging. As President and Managing Partner of the Philadelphia Phoenix, significant revenue growth of over 1500% has been achieved under management. Chung also co-chairs the UFA Inclusion Initiative, aimed at enhancing diversity within the sport of ultimate, and holds multiple roles within the Ultimate Frisbee Association (UFA), including Chief Medical Officer and Chair of the UFA COVID Task Force. Board-certified in dermatology and specializing in cutaneous oncology, Chung has practiced at Schweiger Dermatology Group and previously directed the Drexel Dermatology Center for Transplant Patients. An accomplished academic, Chung has contributed to the field as an Associate Professor at Drexel University College of Medicine, with a focus on cultural competency in dermatologic care.